DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Jeena Sikho Lifecare Limited — Product launch

NSE 54 min ago·2 Sept 2026, 12:59 pm

Jeena Sikho Lifecare

Jeena Sikho Lifecare Limited has informed stock exchanges about the launch of new products. This regulatory filing, made under SEBI disclosure norms, confirms the company is expanding its portfolio. The specific details of these new offerings have not yet been disclosed.

For investors, this news signals potential growth and diversification for the company. A successful product launch can boost revenue streams and strengthen the company's market position. It indicates that the management is actively looking to expand its business operations.

Investors should monitor the official announcements for more details on the new products. Following the launch, it is important to watch the company's sales performance and market reception to gauge the success of this expansion.